Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Clinical Efficacy and Time-to-event Survival in Patients With Degenerative Aortic Valve Disease Scheduled for Stented Biological Aortic Valve Replacement Versus Allograft Aortic Root Replacement.

NCT07210541 is registered in ClinicalTrials.gov with Chelyabinsk Regional Clinical Hospital as lead sponsor.

NCT NCT07210541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07210541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Clinical Efficacy and Time-to-event Survival in Patients With Degenerative Aortic Valve Disease Scheduled for Stented Biological Aortic Valve Replacement Versus Allograft Aortic Root Replacement.
Lead sponsor
Chelyabinsk Regional Clinical Hospital
Phase
Observational
Overall status
Completed
Start date
January 12, 2017
Completion date
September 29, 2025
Enrollment
93 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allograft, bioprosthesis failure